PODD
Insulet Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Insulet (PODD) Stock: Buy, Sell, or Hold?
$150.48
+0.45 (+0.30%)
â˛
5d:
-3.61%
30d:
+12.36%
90d:
+4.98%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect PODD Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (70%)
Quality Score
40/100
Position
FAIR
30-Day Fair Range
$133.65 â $151.27
Position: FAIR
Forward P/E & Valuation
19.0x
CHEAP
vs 26.8x historical avg
Wall Street Target
$178.57
+19.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$143.28 / $168.47
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: PODD is fairly priced but lacks strong directional signals. At -10.9% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 6, 2026 at $144.96 · last confirmed Nov 9, 2026
Strength: 4.6/10
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$322.96
Based on 10.4% avg growth
INTRINSIC VALUE TODAY
$200.53
25.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $150.48, which is considered fair relative to its 30-day fair value range of $133.65 to $151.27. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.0) compared to its historical average (26.8). Remarkably, the market is currently pricing in an annual earnings decline of 10.9% over the next few years. This pessimistic expectation contrasts with the company's recent 63.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a downtrend. Immediate support is located at $143.28, while resistance sits at $168.47.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $178.57 (+19.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PODD is in a downtrend. Immediate support is located at $143.28, while resistance sits at $168.47.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $178.57 (+19.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$133.65 -
$151.27
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
Trading Range & Key Levels
30-Day Trading Range
$133.65 -
$151.27
Current vs Trading Range
FAIR
Support Level
$143.28
Resistance Level
$168.47
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding PODD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($178.57)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
18.97
Wall Street Target
$178.57
(+19.0%)
Revenue Growth (YoY)
19.2%
Earnings Growth (YoY)
63.7%
Profit Margin
13.4%
Valuation Discount vs History
-10.9% cheaper
PE vs Historical
19.0 vs 26.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.9%
(market-implied from PE analysis)
1-Year Target
$135.03
(-10%)
2-Year Target
$121.52
(-19%)
3-Year Target
$109.37
(-27%)
3-Yr Target (if PE normalizes)
(PE: 19â27)
$154.54
(+3%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 16.8%)
$250.06
(+67%)
Base:
(SPY PE: 19.0, Growth: 16.8%)
$238.81
(+59%)
Bear:
(PE: 16.1, Growth: 16.8%)
$202.99
(+35%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 24.19 | Current EPS (TTM): $6.12
Bull Case
$210.51
(+40%)
Analyst growth 29.3%, PE expands to 26.6
Base Case
$191.37
(+28%)
Market implied 29.3%, PE stable at 24.2
Bear Case
$100.68
(-33%)
Severe decline -20.0%, PE contracts to 20.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.0 to 26.8
Stabilization Target:
$211.99
(+41.3%)
PE Expansion Potential:
+41.3%
Share PODD Analysis
Share this live PODD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PODD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 29, 2026
Daily AI digest
AI Retail Discussion Summary:
Insulet (PODD) is expected to report earnings growth next week, according to Wall Street consensus. The stock may react positively or negatively based on the actual results.
Key Retail Themes:
earnings expectations
stock price reaction
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:37 PM ET
Data refreshes hourly during market hours. Next update: 3:37 PM
Data refreshes hourly during market hours. Next update: 3:37 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 54 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 41 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 54 HOLD |
|
ATEC
Alphatec Holdings Inc |
STRONG BUY
14 analysts |
$13 | 66 BUY |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PODD Research Pages
